Articles

Find an Article

Filter articles

Showing 3501 to 3510 of 3745 results

Business brief 2011: Netherlands

Netherlands01-01-2011Michiel Rijsdijk

One can choose to acquire a patent in the Benelux (Belgium, the Netherlands, Luxembourg) via a national patent application or a European patent (EP) application, in which the three Benelux countries will be designated.

Business brief 2011: Norway

Norway01-01-2011Kristina Edén Johnsen and Håkon Svendsen

Protection by patent in Norway is obtained by a national application, by nationalisation of a PCT application before the 31-month term, or by validation of a European patent.

Business brief 2011: Pakistan

Pakistan01-01-2011Hameeda Asif and Ayesha Hasan

Patent rights are governed by the Patents Ordinance, 2000, along with the Patents Rules, 2003.

Business brief 2011: South Africa

South Africa01-01-2011Christel Wolmarans and Herman Blignaut

Trademark rights can be divided into two categories, namely statutory rights and rights afforded by common law.

Business brief 2011: Venezuela

Venezuela01-01-2011Patricia Hoet-Limbourg

There haven’t been any significant changes or developments in Venezuela over the last year that IP professionals and owners need to be aware of.

Life sciences in Europe: the key jurisdictions

EU01-01-2011Biotechnology

The European life sciences industry has a long history. Many of the major players trace their roots to before the war, and often began as agricultural or chemical companies. LSIPR takes a look at the leading jurisdictions.

A revolution: biotech patents in India

India01-01-2011BiotechnologyArchana Shanker

It has taken a long time for India to develop a productive environment for biotechnology. But recent developments look to have put it on the right track. Archana Shanker explains.

It’s good to litigate a patent or two

Germany01-01-2011

Europe is home to many life sciences companies, so IP regimes throughout the continent’s jurisdictions need to provide cost-effective, speedy and certain litigation environments if patent disputes are to be satisfactorily settled.

For better, for worse? How shifting IP laws change the global life sciences regulatory chessboard

Canada, China, Japan, Poland, Thailand, Venezuela01-01-2011BiosimilarsRichard Gough and Jane Woodhouse

With IP laws around the world subject to frequent and sometimes unpredictable changes, it can be difficult to keep abreast of everything you need to know. Richard Gough and Jane Woodhouse take a look.

Covering all the bases: An interview with BIO President Jim Greenwood

01-01-2011Biotechnology

BIO represents a broad constituency of biotechnology and life sciences companies. LSIPR talks to BIO president and CEO Jim Greenwood about patent reform, healthcare, court cases and plans for the future.

Showing 3501 to 3510 of 3745 results

WIPR